Media coverage
2
Media coverage
Title FDA Approves Carvykti for Relapsed or Refractory Multiple Myeloma Media name/outlet Pharmacy Times Country/Territory United States Date 1/03/22 URL https://www.pharmacytimes.com/view/fda-approves-carvykti-for-relapsed-or-refractory-multiple-myeloma Persons Sundar Jagannath Title Cilta-Cel Approved for Relapsed/Refractory Multiple Myeloma Media name/outlet GeneTherapyLive Country/Territory United States Date 1/03/22 URL https://www.genetherapylive.com/view/cilta-cel-carvykti-approved-for-relapsed-refractory-multiple-myeloma Persons Sundar Jagannath